Correction: Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice (Gastroenterology (2010) 139(4) (1320–1332) (S0016508510009030) (10.1053/j.gastro.2010.06.044));Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice

Gastroenterology

Volumn 139, Issue 4, 2010, Pages 1320-1332

  MacKenzie, Gerardo G ^a   Sun, Yu ^a   Huang, Liqun ^a   Xie, Gang ^a   Ouyang, Nengtai ^a   Gupta, Ramesh C ^b   Johnson, Francis ^b   Komninou, Despina ^c   Kopelovich, Levy ^d   Rigas, Basil ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Chem Master International Inc   (United States)

^c Medicon Inc   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colon Cancer; Phospho Sulindac; Polyamines; Reactive Oxygen Species; Sulindac

Indexed keywords

ACYLTRANSFERASE; ANTINEOPLASTIC AGENT; EFLORNITHINE; INDOMETACIN; OXT 328; PHOSPHOSULINDAC; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SPERMIDINE; SPERMINE; SULINDAC; UNCLASSIFIED DRUG; DIAMINE N-ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ORGANOPHOSPHORUS COMPOUND; OXT-328; POLYAMINE; PROSTAGLANDIN E2;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TOXICITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COLONIC NEOPLASMS; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ACETYLTRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; BIOGENIC POLYAMINES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DINOPROSTONE; EFLORNITHINE; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; NF-KAPPA B; ORGANOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SULINDAC;

EID: 77957350899     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.02.001     Document Type: Erratum

References (17)

1. Y. Beazer-Barclay, D.B. Levy, and A.R. Moser Sulindac suppresses tumorigenesis in the Min mouse Carcinogenesis 17 1996 1757 1760
2. E.W. Gerner, and F.L. Meyskens Jr Polyamines and cancer: old molecules, new understanding Nat Rev Cancer 4 2004 781 792
3. F.L. Meyskens Jr, C.E. McLaren, and D. Pelot Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial Cancer Prev Res (Phila Pa) 1 2008 32 38
4. J. Roberts 2d, and J. Morrow Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment gout J.G. Hardman, L.E. Limbird, Goodman and Gilman's The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw-Hill New York 687 731
5. G.A. Piazza, A.B. Keeton, and H.N. Tinsley A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity Cancer Prev Res (Phila Pa) 2 2009 572 580
6. Y. Sun, and B. Rigas The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents Cancer Res 68 2008 8269 8277
7. W. Zhao, G.G. Mackenzie, O.T. Murray, Z. Zhang, and B. Rigas Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect Carcinogenesis 30 2009 512 519
8. J. Gao, X. Liu, and B. Rigas Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress Proc Natl Acad Sci U S A 102 2005 17207 17212
9. N. Seiler, and B. Knodgen High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives J Chromatogr 221 1980 227 235
10. S. Chopra, and H.M. Wallace Induction of spermidine/spermine N1-acetyltransferase in human cancer cells in response to increased production of reactive oxygen species Biochem Pharmacol 55 1998 1119 1123
11. P.E. Whiteley, and S.A. Dalrymple Models of inflammation: measuring gastrointestinal ulcerations in the rat S.J. Enna, Current Protocols in Pharmacology Volume 3 1998 John Wiley & Sons Inc New York
12. N. Babbar, N.A. Ignatenko, R.A. Casero Jr, and E.W. Gerner Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer J Biol Chem 278 2003 47762 47775
13. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436
14. M. Benhar, D. Engelberg, and A. Levitzki ROS, stress-activated kinases and stress signaling in cancer EMBO Rep 3 2002 420 425
15. K. Balmanno, and S.J. Cook Tumour cell survival signalling by the ERK1/2 pathway Cell Death Differ 16 2009 368 377
16. K. Yang, K. Fan, and N. Kurihara Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations Carcinogenesis 24 2003 605 611
17. J.A. Baron What now for aspirin and cancer prevention? J Natl Cancer Inst 96 2004 4 5